Announcement
10 Apr 2023
In April 2023, the US launched a new initiative to combat COVID-19 and future Coronaviruses.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
10 Apr 2023
Revocation date:
No revocation date
Updated: 10 Apr 2023
State aid, unspecified
In force
On 10 April 2023, the US Administration launched a new initiative titled ‘Project Next Gen’ to develop new COVID-19 vaccines and treatments. These new vaccines are expected to be effective against ...
Sign in to see more
Related State Acts
16 Jan 2025
United States of America: BARDA awards Shionogi Inc USD 375 million to support the development of therapeutic medication to prevent COVID-19 for immune-compromised people
26 Sep 2024
United States of America: BARDA awards ModeX Therapeutics USD 35 million to support the development of multispecific antibodies against COVID-19
18 Jun 2024
United States of America: BARDA awards USD 24 million to GeoVax for the clinical trial of novel COVID-19 vaccine
13 Jun 2024
United States of America: BARDA awards USD 453 million to Vaxart for oral COVID-19 vaccine Phase 2b trial
04 Jun 2024
United States of America: BARDA awards USD 40 million to CyanVac for intranasal COVID-19 vaccine Phase 2b trial
03 Jun 2024
United States of America: BARDA awards USD 33 million to CastleVax for intranasal COVID-19 vaccine Phase 2b trial
14 May 2024
United States of America: BARDA provides funding to support the development of decentralized clinical trial (DCT) solutions for vaccine development
03 Oct 2023
United States of America: BARDA awards Vir Biotechnology Inc a contract to support the development of mRNA-expressed monoclonal antibodies
30 Sep 2023
United States of America: BARDA awards Codagenix a contract to support the development of a COVID-19 vaccine candidate
28 Sep 2023
United States of America: BARDA awards American Type Culture Collection (ATCC) a contract to support the clinical studies of COVID-19 vaccine candidates
28 Sep 2023
United States of America: BARDA provides funding to an influenza-like illness detection algorithm
27 Sep 2023
United States of America: BARDA awards Gritstone Bio a contract to support the development of a COVID-19 vaccine candidate
26 Sep 2023
United States of America: BARDA awards Pharmaceutical Product Development a contract to support its laboratory testing capacity for the development of a COVID-19 vaccine candidate
26 Sep 2023
United States of America: BARDA awards ModeX Therapeutics a contract to support the development of a monoclonal antibody against COVID-19
26 Sep 2023
United States of America: BARDA provides funding to support the development of vaccine technologies
26 Sep 2023
United States of America: BARDA awards Meso Scale Diagnostics a contract to support the development of COVID-19 antibody test kits
24 Aug 2023
United States of America: BARDA announces funding to support the development of innovative technologies in vaccines, therapeutics, and biomanufacturing
22 Aug 2023
United States of America: BARDA provides funding to Regeneron to support the development of a COVID-19 monoclonal antibody therapy
22 Aug 2023
United States of America: BARDA awards Rho Federal Systems Division Inc a contract to speed the development of new COVID-19 vaccines
22 Aug 2023
United States of America: BARDA awards ICON GPHS Inc a contract to accelerate the development of new COVID-19 vaccines
04 Jun 2023
United States of America: BARDA announces funding to support the development of innovative solutions addressing potential health security threats
Threads
See all
This state act is not part of any Thread yet.